Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Kindred Biosciences stock

Learn how to easily invest in Kindred Biosciences stock.

Kindred Biosciences Inc is a drug manufacturers-specialty & generic business based in the US. Kindred Biosciences shares (KIN) are listed on the NASDAQ and all prices are listed in US Dollars. Kindred Biosciences employs 63 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Kindred Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KIN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Kindred Biosciences stock price (NASDAQ: KIN)

Use our graph to track the performance of KIN stocks over time.

Kindred Biosciences shares at a glance

Information last updated 2021-10-17.
Latest market close$4.83
52-week range$4.11 - $9.28
50-day moving average $9.20
200-day moving average $6.64
Wall St. target price$9.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.02

Buy Kindred Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Kindred Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kindred Biosciences price performance over time

Historical closes compared with the close of $4.83 from 2021-05-28

1 week (2022-01-14) N/A
1 month (2021-12-21) N/A
3 months (2021-10-21) N/A
6 months (2021-07-25) -47.21%
1 year (2021-01-25) -0.62%
2 years (2020-01-24) -49.16%
3 years (2019-01-25) 10.06
5 years (2017-01-25) 6.4

Kindred Biosciences financials

Revenue TTM $5.8 million
Gross profit TTM $-1,162,000
Return on assets TTM -23.11%
Return on equity TTM -50.36%
Profit margin 0%
Book value $1.76
Market capitalisation $420.5 million

TTM: trailing 12 months

Kindred Biosciences share dividends

We're not expecting Kindred Biosciences to pay a dividend over the next 12 months.

Kindred Biosciences share price volatility

Over the last 12 months, Kindred Biosciences's shares have ranged in value from as little as $4.105 up to $9.28. A popular way to gauge a stock's volatility is its "beta".

KIN.US volatility(beta: 1.32)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kindred Biosciences's is 1.3152. This would suggest that Kindred Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Kindred Biosciences overview

Kindred Biosciences, Inc. , a commercial-stage biopharmaceutical company, engages in developing therapies for pets. Its product pipeline focuses on biologics for a range of indications primarily in dogs and cats. The company offers Mirataz, a mirtazapine transdermal ointment for the management of weight loss in cats; and Zimeta, a dipyrone injection for the control of fever in horses. It also develops KIND-016, a monoclonal antibody for the treatment of atopic dermatitis in dogs; KIND-032, a monoclonal antibody targeting interleukin-4 (IL-4) receptor for the treatment of atopic dermatitis in dogs; KIND-025 a canine fusion protein targeting IL-4 and IL-13 for atopic dermatitis in dogs; KIND-030, a monoclonal antibody targeting canine parvovirus for the prophylactic indication in dogs; KIND-509, an antibody for canine inflammatory bowel disease in dogs; KIND-510a, a long-acting feline recombinant erythropoietin being developed for the management of non-regenerative anemia in cats; and KIND-511, an anti-tumor necrosis factor treatment for newborn foals. The company was incorporated in 2012 and is headquartered in Burlingame, California. As of August 27, 2021, Kindred Biosciences, Inc.

Kindred Biosciences in the news

There are no recent company news

Frequently asked questions

What percentage of Kindred Biosciences is owned by insiders or institutions?
Currently 19.041% of Kindred Biosciences shares are held by insiders and 80.102% by institutions.
How many people work for Kindred Biosciences?
Latest data suggests 63 work at Kindred Biosciences.
When does the fiscal year end for Kindred Biosciences?
Kindred Biosciences's fiscal year ends in December.
Where is Kindred Biosciences based?
Kindred Biosciences's address is: 1555 Bayshore Highway, Burlingame, CA, United States, 94010
What is Kindred Biosciences's ISIN number?
Kindred Biosciences's international securities identification number is: US4945771099
What is Kindred Biosciences's CUSIP number?
Kindred Biosciences's Committee on Uniform Securities Identification Procedures number is: 494577109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site